Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Borislav Dimitrov (Southampton, United Kingdom), Borislav D. Dimitrov, Mohd Hafiz Hj Jaidi. CF-ABLE-UK score: Modification and validation of a clinical prediction rule for prognosis in cystic fibrosis on data from UK CF registry. Eur Respir J 2015; 46: Suppl. 59, 2064

Member's Comments

No comment yet.

Related content which might interest you: Does the lung clearance index track with disease progression in early childhood? Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Year: 2015 Ability of lung clearance index to track changes in a routine clinical CF setting Source: International Congress 2015 – Paediatric respiratory physiology Year: 2015 Use of national disease registries in the conduct of long-term post-authorisation drug safety studies (LTSSs) Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016 Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF Source: Eur Respir J 2001; 18: 298-305 Year: 2001 Impact of frailty on interpretability of spirometry: The Rotterdam study Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population Year: 2013 Lung clearance Index changes over time among patients with cystic fibrosis Source: International Congress 2015 – New findings in paediatric respiratory physiology Year: 2015 Predicting mortality in idiopathic pulmonary fibrosis. Which parameters should be used to determine eligibility for treatment? Analysis of a UK prospective cohort Source: International Congress 2016 – The best is yet to come in terms of lung function Year: 2016 Longitudinal assessment of Lung Clearance Index as a marker of disease progression in a cohort of children with cystic fibrosis and normal spirometry Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology Year: 2020 Relationship of baseline or annual change of clinical parameters on mortality in patients with COPD Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 Correlation of nutritional status using subjective global assessment (SGA) on pulmonary function parameters in patients with COPD at the Philippine Heart Center Source: Annual Congress 2013 –Disease control and quality of life in airway diseases Year: 2013 Respiratory function and the risk of lung cancer in COPD patients: A population-based cohort study Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer Year: 2016 Assessment of NuvoAir platform use on clinical outcomes in adults with cystic fibrosis: a first Italian experience Source: Virtual Congress 2021 – Cystic fibrosis Year: 2021 Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Disease characteristics and outcomes in a Swedish cohort of patients with pulmonary fibrosis (PF) Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up Source: International Congress 2014 – Markers Year: 2014 Validation of a Japanese version of the COPD diagnostic questionnaire in the general Asian population: The Hisayama study Source: Annual Congress 2013 –Treatment of asthma Year: 2013 PROOF-registry: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting Source: International Congress 2014 – ILDs 6 Year: 2014 Assessment of the work of breathing (sWOB) within different functional and genetic groups in patients with cystic fibrosis (CF) Source: Annual Congress 2013 –New perspectives of lung function assessment in children Year: 2013 CPOD and lung function parameters as predictors of mortality: Results from the Latin American PLATINO cohort study Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014